GridAI Technologies Corp (GRDX) Stock Analysis
Verdict: AVOID
Pre-revenue biotech pivot with sub-2-month cash runway faces imminent equity dilution risk and unsustainable capital burn.
Investment score: 16/100
Analysis as of
Is GridAI Technologies Corp stock worth reviewing? The TradeMates thesis
GridAI Technologies Corp faces an extreme liquidity squeeze with under two months of cash runway remaining ($0.90M cash vs. -$5.70M operating cash burn in 2025). The model sees severe risk of equity dilution or restructuring.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 15/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
GridAI Technologies Corp opportunities and risks
What speaks for GRDX
- Potential licensing or clinical milestone for legacy drug candidate Adrulipase
What speaks against GRDX
- Imminent high-volume equity dilution or distressed financing
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| GRDX | n/a | 62.9x | n/a | -1532.5% | -12789.6% | -80.5% |
| TCRX | n/a | 3.1x | n/a | 90.3% | -1655.4% | -542.9% |
| ACTU | n/a | 0.0x | n/a | 0.0% | 0.0% | -82.1% |
| ATOS | n/a | 0.0x | 0.0x | 0.0% | 0.0% | -147.0% |
| CLRB | n/a | 0.0x | 0.6x | 0.0% | 0.0% | -99.9% |
| LTRN | n/a | 0.0x | n/a | 0.0% | 0.0% | -61.4% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -99.9% |
Frequently asked questions about GridAI Technologies Corp (GRDX)
Is GRDX stock a good investment?
The TradeMates model rates GridAI Technologies Corp as AVOID with an investment score of 16/100. GridAI Technologies Corp faces an extreme liquidity squeeze with under two months of cash runway remaining ($0.90M cash vs. -$5.70M operating cash burn in 2025). The model sees severe risk of equity dilution or restructuring. This is algorithmic model output, not personal investment advice.
Is GRDX stock a buy?
The TradeMates model verdict for GRDX is AVOID with an investment score of 16/100. Treat this as a model signal to review, not a personal buy recommendation.